finweek

COVER STORY | A tale of vaccines and constraints on growth

accreditation
Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
Getty Images

The battered global economy is expected to begin its long journey to recovery from the impact of Covid-19 next year, provided that ambitious plans to roll out effective vaccines to billions of people stay on track, reducing the threat of renewed restrictions on activity and alleviating fears of infection.

It already looks like the anticipated bounce in 2021 will be weaker than initially envisaged, following second waves of infections – more severe than the first – which are sweeping across leading economies, like the US, Europe, the UK and Japan.

There are concerns that a second wave is imminent in SA, given a surge in infections in the Eastern and Western Cape at the time of going to print.

Support independent journalism
Subscribe to News24 for just R75 per month to read all our investigative and in-depth journalism. You can cancel any time.
Subscribe
Already a subscriber? Sign in
Rand - Dollar
15.31
+1.4%
Rand - Pound
20.86
+1.2%
Rand - Euro
17.38
+1.2%
Rand - Aus dollar
11.07
+0.8%
Rand - Yen
0.13
+1.1%
Gold
1,842.33
+1.6%
Silver
24.15
+2.9%
Palladium
2,012.00
+5.7%
Platinum
1,033.34
+4.9%
Brent Crude
87.51
+1.2%
Top 40
69,513
+1.8%
All Share
76,176
+1.6%
Resource 10
77,000
+3.3%
Industrial 25
95,623
+1.4%
Financial 15
15,206
-0.9%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot